PLA2G4F Antibody

Code CSB-PA721207LA01HU
Size US$166
Order now
Image
  • IHC image of CSB-PA721207LA01HU diluted at 1:100 and staining in paraffin-embedded human pancreatic cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) PLA2G4F Polyclonal antibody
Uniprot No.
Target Names
PLA2G4F
Alternative Names
cPLA2-zeta antibody; Cytosolic phospholipase A2 zeta antibody; DKFZp666G192 antibody; DKFZp781B229 antibody; PA24F_HUMAN antibody; Phospholipase A2 group IVF antibody; Pla2g4f antibody; PLA2G4FZ antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Cytosolic phospholipase A2 zeta protein (74-299AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The PLA2G4F Antibody (Product code: CSB-PA721207LA01HU) is Non-conjugated. For PLA2G4F Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA721207LB01HU PLA2G4F Antibody, HRP conjugated ELISA
FITC CSB-PA721207LC01HU PLA2G4F Antibody, FITC conjugated
Biotin CSB-PA721207LD01HU PLA2G4F Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Tested Applications
ELISA, IHC
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Has calcium-dependent phospholipase and lysophospholipase activities with a potential role in membrane lipid remodeling and biosynthesis of lipid mediators. Preferentially hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity). Selectively hydrolyzes sn-2 arachidonoyl group from membrane phospholipids, providing the precursor for eicosanoid biosynthesis. In myocardial mitochondria, plays a major role in arachidonate release that is metabolically channeled to the formation of cardioprotective eicosanoids, epoxyeicosatrienoates (EETs).
Gene References into Functions
  1. Observational study of gene-disease association. (HuGE Navigator) PMID: 19913121
  2. Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator) PMID: 20628086
Subcellular Location
Cytoplasm, cytosol. Cell membrane; Peripheral membrane protein. Mitochondrion.
Tissue Specificity
Expressed in myocardium (at protein level).
Database Links

HGNC: 27396

KEGG: hsa:255189

STRING: 9606.ENSP00000371833

UniGene: Hs.231873

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*